| Nome |
# |
|
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes, file e268a72d-cc0b-4c8f-e053-1705fe0a812c
|
85
|
|
Cardiotoxicity of immune checkpoint inhibitors, file e268a72e-e72c-4c8f-e053-1705fe0a812c
|
85
|
|
The innate immune system in chronic cardiomyopathy: A European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC, file e268a72f-1681-4c8f-e053-1705fe0a812c
|
74
|
|
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events, file e268a733-9964-4c8f-e053-1705fe0a812c
|
58
|
|
Prognostic Significance of Left Atrial Volume Dilatation in Patients with Hypertrophic Cardiomyopathy, file e268a72f-81f1-4c8f-e053-1705fe0a812c
|
52
|
|
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, file d0686823-6b2c-4cd7-adeb-4b8adf2864bd
|
43
|
|
CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV., file e268a72d-cc1f-4c8f-e053-1705fe0a812c
|
39
|
|
Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients, file e268a730-61d8-4c8f-e053-1705fe0a812c
|
39
|
|
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs, file e268a72c-ddb3-4c8f-e053-1705fe0a812c
|
36
|
|
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS), file 833f8fba-fde3-4661-bdf1-4441f2f210a5
|
35
|
|
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function, file 65e65944-721b-4d5b-98d9-f8e736c12261
|
34
|
|
Antineoplastic drug-induced cardiotoxicity: A redox perspective, file e268a72f-6989-4c8f-e053-1705fe0a812c
|
29
|
|
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF, file e268a733-a07f-4c8f-e053-1705fe0a812c
|
25
|
|
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients, file e268a733-67f7-4c8f-e053-1705fe0a812c
|
23
|
|
Physical vs. multidimensional frailty in older adults with and without heart failure, file e268a731-5982-4c8f-e053-1705fe0a812c
|
21
|
|
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production, file e268a72f-5e18-4c8f-e053-1705fe0a812c
|
20
|
|
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study, file 51b42f58-cbd3-41ff-9e7b-b71a58a32a7a
|
19
|
|
Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors and clinical impact, file e268a72f-adea-4c8f-e053-1705fe0a812c
|
18
|
|
Recent advances in cardio-oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’, file e268a731-3bdd-4c8f-e053-1705fe0a812c
|
18
|
|
Metabolic Aspects of Anthracycline Cardiotoxicity, file 0d64d286-0094-4a18-8cd0-b91fd64d9222
|
13
|
|
Time-weighted lactate as a predictor of adverse outcome in acute heart failure, file e268a732-c6e3-4c8f-e053-1705fe0a812c
|
13
|
|
Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure, file e268a730-8626-4c8f-e053-1705fe0a812c
|
11
|
|
Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018', file e268a72f-e8d8-4c8f-e053-1705fe0a812c
|
10
|
|
Impaired Cardiac and Skeletal Muscle Energetics Following Anthracycline Therapy for Breast Cancer, file f78e77f1-5c9e-4109-b26d-eb4c03f34f57
|
10
|
|
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology, file 1d86541e-0cd5-467d-92d1-cafac33188e0
|
9
|
|
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments, file bd8e05fc-76aa-4ef3-b5ce-b6e4d6ee52b1
|
9
|
|
Cardiovascular events and treatment of children with high risk medulloblastoma, file e268a733-30ab-4c8f-e053-1705fe0a812c
|
9
|
|
Editorial: Myocardium regeneration and cardioprotection, file 5cb2e4e5-a883-44bf-84db-048195ee501c
|
8
|
|
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions—A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology, file e268a72d-d460-4c8f-e053-1705fe0a812c
|
8
|
|
Modulation of Redox Signaling in Chronic Diseases and Regenerative Medicine, file e268a730-60df-4c8f-e053-1705fe0a812c
|
8
|
|
HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation, file e268a733-d0c6-4c8f-e053-1705fe0a812c
|
8
|
|
The broad spectrum of cardiotoxicities from immunotherapies, file 5695e071-7d90-4c74-810d-67be1383720f
|
6
|
|
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs, file e268a72d-78e2-4c8f-e053-1705fe0a812c
|
5
|
|
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis, file e268a732-c2b4-4c8f-e053-1705fe0a812c
|
5
|
|
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan, file e268a733-a4ad-4c8f-e053-1705fe0a812c
|
5
|
|
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC), file e268a731-b0e8-4c8f-e053-1705fe0a812c
|
4
|
|
Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications, file e268a733-706d-4c8f-e053-1705fe0a812c
|
4
|
|
Pathophysiology of Takotsubo Syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: Overview and the central role for catecholamines and sympathetic nervous system, file e268a733-ab0f-4c8f-e053-1705fe0a812c
|
4
|
|
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers, file 7344b4ea-07ff-4319-b5d3-4732c64e0884
|
3
|
|
Permanent atrial fibrillation and pulmonary embolism in elderly patients without deep vein thrombosis: is there a relationship?, file e268a72f-e0d1-4c8f-e053-1705fe0a812c
|
3
|
|
Innovations in medical therapy of heart failure with reduced ejection fraction, file 2cba9257-fc43-4ab2-a53b-08782bd4d378
|
2
|
|
Priorities in Cardio-Oncology Basic and Translational Science, file 830235bf-e085-44cb-8172-cbb219fe4f05
|
2
|
|
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond, file a4f57996-4a8f-435f-8e2f-a76d89ce7a64
|
2
|
|
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia, file e268a72f-becd-4c8f-e053-1705fe0a812c
|
2
|
|
Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function, file e268a730-4324-4c8f-e053-1705fe0a812c
|
2
|
|
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities, file e268a731-36b9-4c8f-e053-1705fe0a812c
|
2
|
|
Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: Consensus Document from the joint 2019 meeting of the ESC Working Groups of Cellular Biology of the heart and Myocardial Function, file e268a731-8d0e-4c8f-e053-1705fe0a812c
|
2
|
|
Prevention of cancer-therapy-related heart failure, file e268a732-1283-4c8f-e053-1705fe0a812c
|
2
|
|
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, file 7b23aa03-860e-4c6a-a0a5-e53a1b2856a4
|
1
|
|
Impact analysis of heart failure across European countries: an ESC-HFA position paper, file 969454a7-f769-48fc-a27e-eff6ae7c66b5
|
1
|
|
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging, file ded2ddbb-6cdc-4e1e-ac3f-abc0fd1877c1
|
1
|
|
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Role of echocardiography, file e268a72d-cb97-4c8f-e053-1705fe0a812c
|
1
|
|
Current Views on Anthracyclines Cardiotoxicity, file e268a72d-cc0a-4c8f-e053-1705fe0a812c
|
1
|
|
Impaired mitochondrial energy supply coupled to increased H2O2emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes, file e268a72d-cc0d-4c8f-e053-1705fe0a812c
|
1
|
|
Nitroso-Redox Balance and Modulation of Basal Myocardial Function: an Update from the Italian Society of Cardiovascular Research (SIRC)., file e268a72d-cc0f-4c8f-e053-1705fe0a812c
|
1
|
|
Mitral peak early diastolic filling velocity to deceleration time ratio as a predictor of prognosis in patients with chronic heart failure and preserved or reduced ejection fraction., file e268a72d-cc10-4c8f-e053-1705fe0a812c
|
1
|
|
Bidirectional cross-regulation between ErbB2 and β-adrenergic signaling pathways, file e268a72d-cc13-4c8f-e053-1705fe0a812c
|
1
|
|
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology., file e268a72d-cc17-4c8f-e053-1705fe0a812c
|
1
|
|
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection, file e268a72d-cc19-4c8f-e053-1705fe0a812c
|
1
|
|
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction, file e268a72d-cc1b-4c8f-e053-1705fe0a812c
|
1
|
|
Nitroxyl (HNO) for treatment of acute heart failure., file e268a72d-cc1d-4c8f-e053-1705fe0a812c
|
1
|
|
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models., file e268a72d-cc21-4c8f-e053-1705fe0a812c
|
1
|
|
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology., file e268a72d-cc23-4c8f-e053-1705fe0a812c
|
1
|
|
Protective mechanisms of mitochondria and heart function in diabetes., file e268a72d-d466-4c8f-e053-1705fe0a812c
|
1
|
|
Endogenous Cardioprotective Agents: Role in Pre and Postconditioning., file e268a72d-d469-4c8f-e053-1705fe0a812c
|
1
|
|
Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation., file e268a72d-d46c-4c8f-e053-1705fe0a812c
|
1
|
|
Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose., file e268a72d-d46e-4c8f-e053-1705fe0a812c
|
1
|
|
Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literature., file e268a72e-7ba6-4c8f-e053-1705fe0a812c
|
1
|
|
Cardiac Toxicity of Immune Checkpoint Inhibitors: Cardio-Oncology Meets Immunology, file e268a72f-5e19-4c8f-e053-1705fe0a812c
|
1
|
|
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology, file e268a72f-b004-4c8f-e053-1705fe0a812c
|
1
|
|
Novel Therapeutic Approaches and Targets for the Treatment of Cardiovascular and Immunological Diseases, file e268a72f-db4f-4c8f-e053-1705fe0a812c
|
1
|
|
Right heart dysfunction: from pathophysiologic insights to therapeutic options: a translational overview, file e268a72f-df2e-4c8f-e053-1705fe0a812c
|
1
|
|
Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy, file e268a72f-e310-4c8f-e053-1705fe0a812c
|
1
|
|
Molecular Mechanisms of Cardiovascular Damage Induced by Anti-HER-2 Therapies, file e268a72f-e314-4c8f-e053-1705fe0a812c
|
1
|
|
Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors, file e268a72f-e5d8-4c8f-e053-1705fe0a812c
|
1
|
|
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis, file e268a731-817d-4c8f-e053-1705fe0a812c
|
1
|
|
Sex-related differences in COVID-19 lethality, file e268a731-8d11-4c8f-e053-1705fe0a812c
|
1
|
|
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis, file e268a731-b61c-4c8f-e053-1705fe0a812c
|
1
|
|
The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC), file e268a731-d8e3-4c8f-e053-1705fe0a812c
|
1
|
|
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors, file e268a732-2d3b-4c8f-e053-1705fe0a812c
|
1
|
|
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function, file e268a732-5d19-4c8f-e053-1705fe0a812c
|
1
|
|
Common Mechanistic Pathways in Cancer and Heart Failure, file e268a732-67a8-4c8f-e053-1705fe0a812c
|
1
|
|
Cardiovascular safety of the tyrosine kinase inhibitor nintedanib, file e268a732-7e64-4c8f-e053-1705fe0a812c
|
1
|
|
Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula?, file e268a732-af39-4c8f-e053-1705fe0a812c
|
1
|
|
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice, file e268a733-4672-4c8f-e053-1705fe0a812c
|
1
|
|
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart, file e268a733-5c81-4c8f-e053-1705fe0a812c
|
1
|
|
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets, file e268a733-8f70-4c8f-e053-1705fe0a812c
|
1
|
|
Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure, file e268a733-be44-4c8f-e053-1705fe0a812c
|
1
|
| Totale |
964 |